Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
3235328
Reference Type
Journal Article
Title
The amino acid l-lysine blocks the disruptive effect of phencyclidine on prepulse inhibition in mice
Author(s)
Palsson, E; Fejgin, Kim; Wass, C; Engel, JA; Svensson, L; Klamer, D
Year
2007
Is Peer Reviewed?
1
Journal
Psychopharmacology
ISSN:
0033-3158
EISSN:
1432-2072
Volume
192
Issue
1
Page Numbers
9-15
DOI
10.1007/s00213-006-0683-x
Web of Science Id
WOS:000246100300002
Abstract
Rationale The cognitive and attentional deficits observed
in schizophrenic patients are now considered central to the pathophysiology of the disorder.
These deficits include an inability to filter sensory input as measured by, e.g., prepulse
inhibition (PPI) reflex. Administration of phencyclidine (PCP), a drug that can induce a
schizophrenia-like psychosis in humans, disrupts PPI in experimental animals. In rodents, this
PCP-induced deficit can be blocked by pretreatment with nitric oxide (NO) synthase inhibitors.
This suggests that some of the behavioral effects of PCP are mediated via NO. The substrate for
in vivo NO production is L-arginine, and active transport of L-arginine via the cationic amino
acid transporter may serve as a regulatory mechanism in NO production. Objectives The aim of the
present study was to study the effects of L-arginine transport inhibition, using acute and
repeated L-lysine treatment, on PCP-induced disruption of PPI in mice. Results Subchronic, and to
some extent acute, pretreatment with L-lysine blocked a PCP-induced deficit in PPI without
affecting basal PPI. Conclusions L-lysine has been shown to block L-arginine transport in vitro,
most likely via a competitive blockade and down regulation of cationic amino acid transporters.
However, the importance of L-arginine transport as a regulatory mechanism in NO production in
vivo is still not clear. The present results lend further support to the notion that some of the
effects of PCP in the central nervous system are mediated via NO and that L-arginine transport
may play a role in the regulation of NO production in the brain.
Keywords
nitric oxide; prepulse inhibition; schizophrenia; phencyclidine; mice; l-arginine; l-lysine
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity